Automation Paradox: Repetitive Tasks Drive Disengagement in Sterile Compounding

The automation engagement gap

Automation designed to improve safety in sterile compounding may be creating new vulnerabilities. Experts speaking at NHIA26 in Denver warned that highly repetitive automated tasks in home infusion pharmacies are causing technician and pharmacist disengagement—undermining the very safety goals these systems were built to achieve.

"We're not talking about automation itself being the problem, but what happens when you have highly automated tasks that are repetitive and happening frequently that unintentionally introduce some human disengagement," said Jennifer Smith, PharmD, BCSCP, clinical program manager for Wolters Kluwer Compliance Solutions.

The issue manifests in predictable failure modes. Smith described a common TPN compounding error: a technician clamps the wrong line while operating on autopilot, causing the supply line to explode and spray dextrose across the hood. Beyond the immediate contamination, the error forces a complete workflow reset—moving disinfected vials out, recleaning surfaces, and restarting compounding.

Why it matters

IV workflow management systems, automated compounding devices, and gravimetric verification were adopted specifically to reduce human error in sterile compounding. If the cognitive load of repetitive automated tasks is creating new blind spots, health systems need operational countermeasures—not just better technology. The pattern suggests that workflow design and staff rotation may be as critical to patient safety as the automation itself.

Rotation as a countermeasure

Sara Xiong, CPhT, a specialized consultant with Wolters Kluwer, recommended rotating technicians weekly across hazardous compounding, nonhazardous compounding, and ingredient picking. "You're doing repetitive tasks every single day, every week, every month, every year. It's very easy to disengage when you're so comfortable doing something," she said.

Yale New Haven Health Home Infusion has operationalized this approach. Gene B. Decaminada, BSPharm, pharmacy manager for the health system's home infusion program, rotates technicians weekly through three distinct roles: one handles patient refill calls, a second manages supply flow in and out of the cleanroom, and a third performs ISO Class 5 cleaning and compounding inside the cleanroom.

Pharmacist verification risks

For pharmacists, the autopilot risk centers on IV workflow management system verification. Smith cautioned against pharmacists who are "pulled in four different directions" clicking through image sequences without performing independent calculations or examining the physical product.

"Even with magnification, you may not see a floater, a core, or undissolved drug in the picture," Smith said. "It's really important that the pharmacist is doing that final check."

Glen Gard, CPhT-Adv, CSPT, senior director of sterile compounding at Option Care Health, noted a specific IVWMS limitation in home infusion: systems require scanning only one vial even when compounding a week's supply with 20-plus vials. "Making sure you have the correct photos or scans or other processes to ensure that that detail is being caught and reviewed" becomes essential, he said.

Downtime exposes skill gaps

When automated systems fail, staff who have become dependent on technology must execute manually under pressure. Gard emphasized the need for redundancy: compounding agreements with sister locations, practiced paper-based processes, and backup engineering controls.

"Training staff in manual processes is essential," Gard said. System backups and the ability to extract data from IVWMS become critical for prioritizing patient needs during outages.

Decaminada described Yale New Haven's communication safeguards: hands-free speakers connect the buffer room directly to the clinical area, and the cleanroom operates on a "stop the line" principle borrowed from Toyota manufacturing. If something looks wrong, technicians stop immediately and consult with pharmacists.

These details were first reported by Pharmacy Practice News, based on presentations at the NHIA26 conference. The sources reported no financial conflicts of interest.